Drug Information

Drug General Information
Drug ID
D02NSF
Former ID
DIB004983
Drug Name
Oxymorphone
Synonyms
Oxymorphone (abuse-resistant, pain); Oxymorphone (abuse-resistant, pain), Pain Therapeutics/ King Pharmaceuticals; Oxymorphone (abuse-resistant, pain), Pain Therapeutics/Pfizer
Drug Type
Small molecular drug
Indication Moderate to severe pain [ICD10:R52, G89] Approved [551871]
Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Phase 4 [522753], [542100]
Therapeutic Class
Neurology Agents
Company
Pain Therapeutics Inc
Structure
Download
2D MOL

3D MOL
Formula
C17H19NO4
InChIKey
UQCNKQCJZOAFTQ-ISWURRPUSA-N
PubChem Compound ID
5284604
PubChem Substance ID
10219, 81989, 841905, 11039374, 14751763, 14898432, 39317908, 46505296, 48416368, 50523562, 57359138, 92714667, 96025010, 103250876, 103916122, 118046192, 126629458, 129404545, 134223676, 134338383, 134971543, 137003774, 139076556, 152101651, 160964525, 162224633, 175267332, 178103672, 179117107, 210279774, 210282097, 223440572, 223822210, 226395721, 252355643
Target and Pathway
Target(s) Opioid receptor Target Info Modulator [542100]
References
Ref 522753ClinicalTrials.gov (NCT00955110) Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin). U.S. National Institutes of Health.
Ref 542100(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094).
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 542100(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.